Abstract

ObjectiveMany primary tumors have insufficient supply of molecular oxygen, called hypoxia. Hypoxia is one of the leading characteristics of solid tumors resulting in a higher risk of local failure and distant metastasis. It is quite necessary to investigate the hypoxia associated molecular hallmarks in breast cancer.Materials and MethodsAccording to the published studies, we selected 13 hypoxia related gene expression signature to define the hypoxia status of breast cancer using ConsensusClusterPlus package based on the data from The Cancer Genome Atlas (TCGA). Subsequently, we characterized the infiltration of 24 immune cell types under different hypoxic conditions. Furthermore, the differentially expressed hypoxia associated microRNAs, mRNAs and related signaling pathways were analyzed and depicted. On this basis, a series of prognostic markers related to hypoxia were identified and ceRNA co-expression networks were constructed.ResultsTwo subgroups (cluster1 and cluster2) were identified and the 13 hypoxia related gene signature were all up-regulated in cluster1. Thus, we defined the cluster1 as “hypoxic subgroup” compared with cluster2. The infiltration of CD8+ T cell and CD4+ T cell were lower in cluster1 while the nTreg cell and iTreg cell were higher, indicating that there was immunosuppressive status in cluster1. We observed widespread hypoxia-associated dysregulation of microRNAs and mRNAs. Next, a risk signature for predicting prognosis of breast cancer patients was established based on 12 dysregulated hypoxia associated prognostic genes. Two microRNAs, hsa-miR-210-3p and hsa-miR-190b, with the most significant absolute logFC value were related to unfavorable and better prognosis, respectively. Several long non-coding RNAs were predicted to be microRNA targets and positively correlated with two selected mRNAs, CPEB2 and BCL11A. Predictions based on the LINC00899/PSMG3-AS1/PAXIP1-AS1- hsa-miR-210-3p-CPEB2 and SNHG16- hsa-miR-190b-BCL11A ceRNA regulation networks indicated that the two genes might act as tumor suppressor and oncogene, respectively.ConclusionHypoxia plays an important role in the initiation and progression of breast cancer. Our research provides potential mechanisms into molecular-level understanding of tumor hypoxia.

Highlights

  • Statistics from the International Cancer Research Center show that breast cancer morbidity and mortality rank first and second among female tumors

  • Predictions based on the LINC00899/PSMG3-AS1/PAXIP1-AS1- hsa-miR-210-3pCPEB2 and SNHG16- hsa-miR-190b-BCL11A competitive endogenous RNAs (ceRNAs) regulation networks indicated that the two genes might act as tumor suppressor and oncogene, respectively

  • We selected 13 hypoxia related gene expression signature for our analysis: ADM, TUBB6, MRPS17, CDKN3, TPI1, ALDOA, MIF, PGAM1, LDHA, P4HA1, SLC2A1, NDRG1, and VEGFA. These genes were defined based on hypoxia-related gene function and were highly enriched for hypoxia-regulated pathways [11, 12], and their cellular pathways and functions were shown in Table

Read more

Summary

Introduction

Statistics from the International Cancer Research Center show that breast cancer morbidity and mortality rank first and second among female tumors. Hypoxia in the local microenvironment can promote the formation of new blood vessels by inducing Hypoxia-inducible factor 1-alpha (HIF-1a) [6], Vascular endothelial growth factor (VEGF) [7], C-C Motif Chemokine Ligand 28 (CCL28) [8] and other cytokines, and regulate the expression of the signal cascade and downstream related genes, thereby promoting the proliferation and invasion of tumor cells [9]. It has been demonstrated that the expression level of HIF-1a in breast cancer and other tumor tissues is significantly higher than that in adjacent tissues, and its increase is positively correlated with the incidence of breast cancer metastasis and mortality [10]. Exploring the exact or related mechanism of hypoxia in tumorigenesis and development is expected to provide new targets and indicators for the treatment and prognostic detection of breast cancer. Due to variations of oxygen levels in different tissues, it is still difficult to determine the hypoxia status in tumors

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call